Transient type III atrioventricular block after infliximab infusion in a fistulizing perianal Crohn's disease patient [21]

American Journal of Gastroenterology

Volumn 102, Issue 1, 2007, Pages 217-219

  Sofos, Spyridon ^a   Savoye, Guillaume ^a   Ramirez, Simon ^a   Bauer, Fabrice ^a   Lerebours, Eric ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DEXCHLORPHENIRAMINE; FERROUS SULFATE; HYDROCORTISONE; INFLIXIMAB; MESALAZINE;

ADULT; ANAMNESIS; ANUS FISTULA; ATRIOVENTRICULAR BLOCK; BLOOD PRESSURE; CASE REPORT; COLON CROHN DISEASE; DIZZINESS; DRUG INDICATION; DRUG INFUSION; FEMALE; HEART RATE; HOSPITAL DISCHARGE; HUMAN; LETTER; MAINTENANCE THERAPY; PANCREATITIS; PATIENT MONITORING; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SIDE EFFECT; SYMPTOM; SYNCOPE;

ADULT; ANTIBODIES, MONOCLONAL; CROHN DISEASE; ELECTROCARDIOGRAPHY; FEMALE; GASTROINTESTINAL AGENTS; HEART BLOCK; HUMANS;

EID: 33846101076     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.00916.x     Document Type: Letter

References (10)

1. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial. Lancet 2002;359:1541-9.
2. Rutgeerts P, Sandborn W, Feagan B, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353:2462-76.
3. Cheifetz A, Smedley M, Martin S, et al. The incidence and management of infusion reactions to infliximab: A large center experience. Am J Gastroenterol 2003;98:1315-24.
4. Seiderer J, Goke B, Ochsenkuhn T. Safety aspects of infliximab in inflammatory bowel patients. A retrospective cohort study in 100 patients. Digestion 2004;70:3-9.
5. Colombel JF, Loftus EV, Tremaine WJ, et al. The safety profile of infliximab in patients with Crohn's disease: The Mayo Clinic experience in 500 patients. Gastroenterology 2004;126:19-31.
6. Anand CP, Al-Juburi A, Bhargava S. Heart block occurring during infliximab infusion: A report of two cases. Am J Gastroenterol 2003;98:S419.
7. Sood A, Midha V. Symptomatic sinus bradycardia with infliximab. Indian J Gastroenterol 2004;23:118-9.
8. Kwon HJ, Cote TR, Cuffe MS, et al. Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med 2003;138:807-11.
9. Gupta S, Tripathi CD. Current status of TNF blocking therapy in heart failure. Indian J Gastroenterol 2005;59:363-6.
10. Ballinger A, Farthing MJG. Ulcerative colitis complicated by wenckenbach atrioventricular block. Gut 1992;33:1427-9.